Pharma Journalist -

QIAGEN announced a new collaboration with NVIDIA aimed at integrating accelerated computing and artificial intelligence into drug discovery workflows, a move the company says could help…
Read More...

Global pharmaceutical company Merck & Co. has announced positive pivotal Phase 3 results for sacituzumab tirumotecan (sac-TMT), an investigational TROP2-directed antibody-drug…
Read More...

Takeda Pharmaceutical Company said a U.S. federal jury has returned a verdict against the company in long-running antitrust litigation involving constipation drug AMITIZA, awarding…
Read More...

Regeneron Pharmaceuticals has entered into a strategic research collaboration with Parabilis Medicines to discover and develop a new class of therapeutics designed to target…
Read More...

VERTANICAL said the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to VER-01, the company’s investigational non-opioid treatment for chronic low back…
Read More...

Owkin has entered into a new multi-year agreement with AstraZeneca to develop specialized artificial intelligence agents designed to support biopharmaceutical decision-making and…
Read More...

AstraZeneca announced positive interim results from the Phase III VOLGA clinical trial, showing that perioperative treatment with Imfinzi combined with neoadjuvant enfortumab vedotin…
Read More...

Arna Pharma Inc. and Slate Run Pharmaceuticals have officially finalized a joint venture aimed at creating a larger U.S.-based specialty pharmaceutical company focused on branded…
Read More...

Bristol Myers Squibb and Hengrui Pharma have entered into a broad strategic collaboration and licensing agreement focused on developing innovative medicines across oncology, hematology,…
Read More...

Pfizer Inc. announced that the European Commission has approved an expanded indication for HYMPAVZI, allowing its use in patients aged 12 years and older with hemophilia A or hemophilia…
Read More...